CR-CP Life Science Fund

Venture Capital Active China
Last updated 2026-06-18
Portfolio
2
in our dataset
Rounds participated
2
Rounds led
2
Rounds' value
$37.3M
total disclosed, rounds participated
Stages
—

Portfolio · 2

EyeYon Medical
Ophthalmic Products for Vision-threatening Conditions
Led ★ 1 round $25.0M committed Latest: 2021-03
BELKIN Vision
One-second Laser Treatment for Glaucoma
Led ★ 1 round $12.3M committed Latest: 2020-07

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences2

Q&A

What is CR-CP Life Science Fund's primary investment focus?
CR-CP Life Science Fund primarily invests in the Health Tech & Life Sciences sector, with all of its portfolio companies and exits falling within this category.
Can you name some of CR-CP Life Science Fund's notable portfolio companies?
CR-CP Life Science Fund's portfolio includes BELKIN Vision, which develops one-second laser treatments for glaucoma.
Has CR-CP Life Science Fund had any recent exits?
Yes, CR-CP Life Science Fund had an exit in July 2024 when BELKIN Vision was acquired by Alcon Pharmaceuticals for $81M.
What is CR-CP Life Science Fund's typical investment stage?
CR-CP Life Science Fund has participated in B Round and C Round investments, with one investment in each stage.
When did CR-CP Life Science Fund make its most recent portfolio investments?
CR-CP Life Science Fund made new portfolio investments in July 2020 and March 2021.
What is the investment range for CR-CP Life Science Fund?
CR-CP Life Science Fund's investment range is between $12.25M and $25M.